News | August 14, 2014

Sluggish Economy, Not Health Reform, Drove Slowdown in Health Spending, Says Health Affairs Study

Northwestern University economists use HCCI data to show that health spending is not recession proof

August 14, 2014 — Approximately 70 percent of the recent decline in healthcare spending growth from 2009-2011 was due to the economic downturn, and not to other factors such as health sector responses to the Affordable Care Act, according to a new study published in the August issue of Health Affairs. As the economy recovers, health spending is likely to increase at a faster pace, conclude the authors, David Dranove, Craig Garthwaite and Christopher Ody of the Kellogg School of Management at Northwestern University.

"The source of the slowdown in healthcare spending growth, and whether this slowdown will continue, has been much debated," said Dranove, a professor at the Kellogg School of Management at Northwestern University. "Our analysis shows that the slowdown was mostly due to the sluggish economy, not to structural change in the healthcare sector. The Affordable Care Act may ultimately succeed at reducing costs, but it hasn't done so yet."

The Northwestern researchers are among the first to pinpoint the effect of the economic slowdown on healthcare spending for the privately-insured, working-age population. They examined private insurance claims data covering 2007-2011 from the Health Care Cost Institute (HCCI), which represents the healthcare spending of nearly 47 million people with employer-sponsored insurance in all 50 states.

From 2009-2011, health spending growth for this population slowed by 2.6 percentage points from the previous two years. By calculating the overall decline in employment during this period, the authors predict that health-spending growth would have been 1.8 percentage points higher if the economy had not faltered in 2008. Thus, they concluded that 70 percent of the decline in healthcare spending growth was the result of the stagnant economy.

"There has been disagreement over the years as to whether health spending is recession proof. This study shows it's not," said Garthwaite, an assistant professor at the Kellogg School of Management.

The analysis, which focuses on privately-insured individuals, highlights that the slowdown in health spending was not only caused by individuals who lost their jobs and employer-provided health insurance.

"Even individuals who retained insurance during the downturn reigned in their health spending. This demonstrates the broad effects of a recession on health spending," said Garthwaite.

The researchers compared health spending in areas of the country affected by the economic downturn with areas that were largely unaffected. Insured people living in the hardest hit areas experienced the smallest increases in health spending.

For example, from 2008-2009, Las Vegas — a particularly hard-hit region — experienced a 5.6 percentage point decline in the fraction of residents working. From 2007 to 2011, health spending in Las Vegas increased 5.4 percent. In contrast, Trenton, N.J., saw a 1.6 percentage point decline in the fraction of residents working and a 29 percent increase in health spending.

"The majority of Americans have private insurance, so understanding their health spending patterns is critical to understanding what influences national healthcare expenditures," said HCCI Executive Director David Newman. "Our partnerships with academic researchers like Northwestern are starting to shed light on the forces driving healthcare cost growth and foster solutions that lead to better and more affordable care."

For more information: content.healthaffairs.org/content/33/8/1399.abstract

Related Content

FDA Releases New Report Assessing Quality, Safety and Effectiveness of Medical Device Servicing
News | Cardiovascular Business | June 07, 2018
A new report from the U.S. Food and Drug Administration (FDA) discusses the continued quality, safety and effectiveness...
DAIC Editor Dave Fornell won the 2018 AZBEE national silver award for best blog for "The Future of Cardiology: 17 Technologies to Watch. DAIC magazine - diagnostic and interventional cardiology magazine.
News | Cardiovascular Business | May 14, 2018
May 14, 2018 — Diagnostic and Interventional Cardiology (DAIC) magazine was honored with a ...
FDA Announces New Medical Device Safety Action Plan
News | Cardiovascular Business | April 25, 2018
The U.S. Food and Drug Administration (FDA) released a new Medical Device Safety Action Plan outlining how the agency...
DAIC Wins Two 2018 Regional Azbee Awards for Editorial Excellence
Feature | Cardiovascular Business | April 20, 2018
Diagnostic and Interventional Cardiology was honored with a pair of Azbee Awards for editorial excellence at the 2018...
DAIC Editor Dave Fornell displays the 2018 Neal Award for Best Use of Social Media
News | Cardiovascular Business | April 05, 2018
April 5, 2018 — Diagnostic and Interventional Cardiology (DAIC) magazine received the 2018 Jesse H.
Veritas Capital Acquiring Three Software Units from GE Healthcare
News | Cardiovascular Business | April 02, 2018
GE Healthcare announced the sale of its Value-Based Care Division — including its software assets for Enterprise...
The annual Azbee Awards are hosted by the American Society of Business Publication Editors (ASBPE) to recognize editorial and design excellence in the business, trade and specialty press. Dave Fornell won blog award for DAIC
News | Cardiovascular Business | March 08, 2018
Scranton Gillette Communications’ Diagnostic and Interventional Cardiology (DAIC) was recently named a 2018
Fysicon announced its acquisition by Canon Medical Systems Corporation.
News | Cardiovascular Business | March 08, 2018
Fysicon announced its acquisition by Canon Medical Systems Corporation. Linda Elberse, CEO of Fysicon, stated: "Being...
ACC 2018 Cardiovascular Summit Teaches Cardiology Best Practices
News | Cardiovascular Business | February 28, 2018
The American College of Cardiology’s Cardiovascular Summit will begin on Thursday, Feb. 22, 2018, bringing together...
FDA Releases Final Rule on Data Acceptance from Medical Device Clinical Investigations
News | Cardiovascular Business | February 21, 2018
The U.S. Food and Drug Administration (FDA) issued the final rule on “Human Subject Protection; Acceptance of Data from...
Overlay Init